Key result
Non-pharmacological therapies, including automatic cardioverter-defibrillators and surgery, provide new therapeutic possibilities for ventricular tachyarrhythmias, though electrical ablation remains experimental.
Non-pharmacological therapies, particularly automatic cardioverter-defibrillators, offer significant therapeutic benefits for ventricular tachyarrhythmias, though careful patient selection is required.
Electrical ablation may offer curative potential in selected VT patients; leaves open its role versus modern ICD therapy.
In recent years, development of non-pharmacological therapy has provided new therapeutic possibilities for patients with ventricular tachyarrhythmias. One of the major advances is the automatic cardioverter-defibrillator which has reduced dramatically the number of arrhythmic deaths in patients with ventricular tachycardia or fibrillation. Surgery of ventricular arrhythmias represents an interesting alternative in selected patients as it provides a cure. Electrical ablation of the arrhythmogenic substrates is still experimental. The mortality associated with the procedure in patients with coronary artery disease represents a serious limitation. A careful selection of the indications in order to tailor therapy to the patient is needed and guidelines are proposed.
No takes yet. Share an insight, caveat, or question.
S Lévy (1989) conducted a review in Ventricular tachyarrhythmias. Non-pharmacological therapy (automatic cardioverter-defibrillator, surgery, electrical ablation) was evaluated. Non-pharmacological therapies, including automatic cardioverter-defibrillators and surgery, provide new therapeutic possibilities for ventricular tachyarrhythmias, though electrical ablation remains experimental.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: